Hamdard Launches Jigreen For Liver Disorder
Business Standard quoted Arshad Siddiqui, chief marketing officer of Hamdard Laboratories, saying: “The company will focus on the south markets, particularly Andhra Pradesh. It garnered 9 to 10%
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.